BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED

Biofil Chemicals and Pharmaceuticals Limited

BIOFILCHEM

INE829A01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-05-28 am EDT			5-day change	1st Jan Change
63.82 ^INR	-2.62%		-8.11%	+18.12%

Mar. 29	Biofil Chemicals and Pharmaceuticals Limited Announces Smt. Shaila Jain Will Retire from Independent Directorship as Well as from All the Committees of Board of Directors, Effective 31 March, 2024	CI
Feb. 06	Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021

August 13, 2021 at 08:32 am EDT

Biofil Chemicals and Pharmaceuticals Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 53.894 million compared to INR 29.372 million a year ago. Net income was INR 1.739 million compared to INR 2.166 million a year ago. Basic earnings per share was INR 0.11 compared to INR 0.13 a year ago.

Latest news about Biofil Chemicals and Pharmaceuticals Limited

Biofil Chemicals and Pharmaceuticals Limited Announces Smt. Shaila Jain Will Retire from Independent Directorship as Well as from All the Committees of Board of Directors, Effective 31 March, 2024	Mar. 29	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 06	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Biofil Chemicals and Pharmaceuticals Limited Announces Change in Designation of Gayatri Padiyar from Additional Director to Non-Executive Independent Director	23-09-27	CI
Biofil Chemicals and Pharmaceuticals Limited Announces Management Changes	23-08-14	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Biofil Chemicals and Pharmaceuticals Limited Announces Changes in Company Secretary / Compliance Officer	22-12-23	CI
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Shikha Khilwani as Company Secretary and Compliance Officer, Effective 23 December, 2022	22-12-16	CI
Biofil Chemicals and Pharmaceuticals Limited Appoints Pawan Singh Rajput as Chief Financial Officer	22-11-15	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09	CI
Biofil Chemicals CFO Resigns	22-06-22	MT
Biofil Chemicals and Pharmaceuticals Limited Announces Resignation of Jitendra Kumar Sahu as CFO , Effective on June 30, 2022	22-06-22	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-30	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-12	CI
Biofil Chemicals and Pharmaceuticals Limited Appoints Ramesh Shah as Chairman	21-08-13	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-13	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-30	CI
Biofil Chemicals and Pharmaceuticals Limited Appoints Satish Beohar as Additional Director as Well as Independent Director	21-06-30	CI
Biofil Chemicals and Pharmaceuticals Limited Announces Demise of Subhash Chandra Swarnakar, Non-Executive Independent Director	21-04-23	CI
Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-12	CI

Chart Biofil Chemicals and Pharmaceuticals Limited

Duration

Period

Chart Biofil Chemicals and Pharmaceuticals Limited

More charts

Company Profile

Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Companyâs product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED	+18.12%	12.83M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.31%	42.32B
OTSUKA HOLDINGS CO., LTD.	+16.32%	21.29B
SANDOZ GROUP AG	+19.33%	15.29B
CIPLA LIMITED	+18.71%	14.36B
ZYDUS LIFESCIENCES LIMITED	+52.78%	12.81B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.24%	6.58B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.64%	5.51B